CorePlus – leading the way for AI adoption in digital pathology

Watch this interview with CorePlus CEO Mariano de Socarraz and CMO Juan Carlos Santa-Rosario MD to learn why they have chosen to use AI in primary diagnosis, the benefits it brings, and the impact using AI has had on patient care.

The current Ibex offering was formerly known as Galen. Please note that any mention of Galen within these materials refers to a product now known as Ibex.

Share this article:

Subscribe to our newsletter:

By providing my details I agree that my data will be handled in accordance with IBEX Privacy Policy.

How is artificial intelligence rising to the challenge in breast cancer diagnosis?
How ‘game-changing’ AI is helping discover cancer for the first time in UK | ITV News
The AI revolution in cancer diagnostics with Joseph Mossel, CEO of Ibex Medical Analytics
Scroll to Top
IBEX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.